Seroprevalence of CMV and HSV in Kidney Transplant Donor Candidates and Recipients at Ngoerah Hospital, Denpasar

  • Ni Nyoman Ayu Trisnawati Internal Medicine Specialist Education Program, Faculty of Medicine, Udayana University/ Ngoerah Hospital, Denpasar, Bali, Indonesia.
  • I Ketut Agus Somia Department of Internal Medicine, Faculty of Medicine, Udayana University/ Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Yenny Kandarini Department of Internal Medicine, Faculty of Medicine, Udayana University/ Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Bali, Indonesia
Keywords: Seroprevalence, Cytomegalovirus, Herpes Simplex Virus, Kidney Transplantation, Donor Screening

Abstract

Background: Despite significant advancements in solid organ transplantation over recent decades, infections remain a leading cause of morbidity and mortality among transplant recipients. Herpesviruses, particularly Cytomegalovirus (CMV) and Herpes Simplex Virus (HSV), are the most common viral pathogens affecting this patient population. This study aims to evaluate the seroprevalence of CMV and HSV infections among kidney transplant donor and recipient candidates at RS. Ngoerah Denpasar.

Methods: This descriptive study involved 66 adult subjects, comprising 33 kidney transplant donor candidates and 33 recipient candidates, all aged over 18 years. The study participants were evaluated for CMV and HSV seroprevalence using serological tests, including IgG and IgM antibodies, to determine the presence of latent or active infections. The study population included patients with chronic kidney disease (CKD) stage V who were candidates for kidney transplantation.

Results: Among the 33 donor candidates, 39.4% were found to have both CMV and HSV infections, with 45.5% testing positive for IgG anti-CMV, indicating a latent CMV infection. In the recipient candidate group, 27.3% were infected with both CMV and HSV, with 42.4% showing seropositivity for IgG anti-CMV. Additionally, a small proportion of donor and recipient candidates were found to have reactivated HSV infections, as indicated by the presence of IgM antibodies. The study highlights the significant prevalence of CMV and HSV infections among kidney transplant donor and recipient candidates.

Conclusion: These findings underscore the importance of thorough serological screening prior to transplantation to identify latent infections that may influence post-transplant outcomes.

Downloads

Download data is not yet available.

References

1. Carratalà J, Montejo M, Pérez-Romero P. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients. Enferm Infecc Microbiol Clin. 2012 Mar;30(SUPPL.2):63–9.
2. Jorgenson MR, Descourouez JL, Astor BC, Smith JA, Aziz F, Redfield RR, et al. Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year Perspective. Virology (Auckl). 2019 Mar 1;10.
3. Fishman JA, Rubin RH. Infection in Organ-Transplant Recipients. New England Journal of Medicine. 1998 Jun 11;338(24):1741–51.
4. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med. 1981 Feb;70(2):405–11.
5. Kontoyiannis DP, Rubin RH. Infection in the organ transplant recipient. An overview. Infect Dis Clin North Am. 1995 Dec;9(4):811–22.
6. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States. JAMA. 2006 Aug 23;296(8):964.
7. Zuckerman R, Wald A. Herpes Simplex Virus Infections in Solid Organ Transplant Recipients. American Journal of Transplantation. 2009 Dec;9:S104–7.
8. Munksgaard B. Screening of donor and recipient prior to solid organ transplantation Background. American Journal of Transplantation. 2004;4(10):10–20.
9. Fischer SA, Lu K. Screening of donor and recipient in solid organ transplantation. American Journal of Transplantation. 2013 Mar;13(SUPPL.4):9–21.
10. Caliendo A. Approach to the diagnosis of cytomegalovirus infection. UpToDate. 2022.
11. Mondaca R, Fica A, Delama I, Olivares F, Navarrete M. Cytomegalovirus infection in AIDS patients. An illustrative case series. Vol. 148, Rev Med Chile. 2020.
12. Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018 Jun;102(6):900–31.
13. Rolling KE, Jorgenson MR, Descourouez JL, Mandelbrot DA, Redfield RR, Smith JA. Ganciclovir‐Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2017 Oct 3;37(10):1258–71.
14. Trung Hieu H, Tien Sy B. Risk Factors for Polyomavirus, Cytomegalovirus, and Viruria Co-Infection for Follow-Up of Renal Transplant Patients. Ann Transplant. 2022 Oct 25;27:e937771.
15. Stratta RJ, Thacker LR, Sundberg AK. Multivariate Analysis of the Influence of Donor and Recipient Cytomegalovirus Sero-Pairing on Outcomes in Simultaneous Kidney-Pancreas Transplantation: The South- Eastern Organ Procurement Foundation Experience. Transplant Proc. 2005 Mar;37(2):1271–3.
16. Hughes D, Hafferty J, Fulton L, Friend P, Devaney A, Loke J, et al. Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients. Journal of Clinical Virology. 2008 Feb;41(2):92–5.
17. Díaz JS, Jaimes FA. Cytomegalovirus Disease, Short-Term Cardiovascular Events and Graft Survival in a Cohort of Kidney Transplant Recipients With High CMV IgG Seroprevalence. Progress in Transplantation. 2021 Jun 1;31(2):126–32.
18. Law JP, Borrows R, McNulty D, Sharif A, Ferro CJ. Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients. BMC Nephrol. 2021 Dec 1;22(1).
19. Lee S, Brook E, Affandi J, Howson P, Tanudjaja SA, Dhaliwal S, et al. A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population. Clin Transl Immunology. 2019;8(2).
20. Srivastava A, Bagchi S, Singh S, Balloni V, Agarwal S. Assessment of risk factors and outcome of early versus late cytomegalovirus infection infection in living-related D+/R + renal allograft recipients. Indian J Nephrol. 2022;32(1):47.
21. Ishikawa S, Tasaki M, Saito K, Nakagawa Y, Ikeda M, Takahashi K, et al. Long-term CMV monitoring and chronic rejection in renal transplant recipients. Front Cell Infect Microbiol. 2023;13.
22. Griffiths WJH, Wreghitt TG, Alexander GJ. Reactivation of Herpes Simplex Virus after Liver Transplantation. Transplantation. 2005 Nov;80(9):1353–4.
23. Singh N, Dummer JS, Kusne S, Breinig MK, Armstrong JA, Makowka L, et al. Infections with Cytomegalovirus and Other Herpesviruses in 121 Liver Transplant Recipients: Transmission by Donated Organ and the Effect of OKT3 Antibodies. Journal of Infectious Diseases. 1988 Jul 1;158(1):124– 31.
24. Dummer JS, Armstrong J, Somers J, Kusne S, Carpenter BJ, Rosenthal JT, et al. Transmission of Infection with Herpes Simplex Virus by Renal Transplantation. Journal of Infectious Diseases. 1987 Feb 1;155(2):202–6.
25. Khameneh ZR, Sepehrvand N, Taghizadeh-Afshari A, Motazakker M, Ghafari A, Masudi S. Seroprevalence of Herpes Simplex Virus-2 in Kidney Transplant Recipients A Single-Center Experience [Internet]. Vol. 4, Iranian Journal of Kidney Diseases |. 2010. Available from: www.SID.ir
26. Seale L, Jones CJ, Kathpalia S, Jackson GG, Mozes M, Maddux MS, et al. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA. 1985 Dec 27;254(24):3435–8.
27. Tang IY, Maddux MS, Veremis SA, Bauma WD, Pollak R, Mozes MF. Low- dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy. Transplant Proc. 1989 Feb;21(1 Pt 2):1758–60.
28. Buell C, Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol. 2008 Aug;7(8):741–8.
29. Kang YN, Oh HK, Chang YC, Kim HC, Lee SL, Hwang M, et al. Systemic Herpes Simplex Virus Infection Following Cadaveric Renal Transplantation: A Case Report. Transplant Proc. 2006 Jun;38(5):1346–7.
Published
2026-04-24
How to Cite
1.
Trisnawati NN, Somia IK, Kandarini Y. Seroprevalence of CMV and HSV in Kidney Transplant Donor Candidates and Recipients at Ngoerah Hospital, Denpasar. inakidney [Internet]. 24Apr.2026 [cited 24Apr.2026];3(1):177-88. Available from: https://inakidneyhypertension.co.id/index.php/inakidney/article/view/198
Issue
Vol 3 No 1 (2026): Vol 3 No 1 (2026): Volume 3 No. 1, April 2026
Section
Original Articles

Copyright (c) 2026 Indonesian Journal of Kidney and Hypertension

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:

  1. Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.